Frequently Asked Questions
The global refractive surgery devices market was valued at USD 171.5 Million in 2022.
The refractive surgery devices market is expected to grow at a CAGR of 7.90% between 2023 and 2030, reaching USD 292.02 Million in 2030.
Lazers is the leading segment by product, in terms of value in 2022.
The Myopia segment is the dominant in terms of demand for refractive surgery devices in the world.
The Hospitals segment is expected to post the highest CAGR during the forecast period.
North America is fueling the growth of the refractive surgery devices industry, with over one-third share in 2022.
The top players include Johnson & Johnson Services, Inc.; Carl Zeiss Meditec AG; Alcon; Bausch & Lomb Incorporated; Quantel Medical; TOPCON CORPORATION; Essilor; NIDEK CO., LTD.; SCHWIND eye-tech-solutions.
Rise in geriatric population and the increased screen time of the global population are the major market drivers.
High price and poor adoption rates in terms of refractive surgery devices are the major market restraints.
Advent of technologically advanced minimally invasive surgeries are the major opportunities in the refractive surgery devices industry.